Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Cabergoline 0.5 MG
OTHER:
Placebo
Sponsor
University of Aarhus